Under the agreement, the board’s healthcare division will become a wholly-owned subsidiary of Optum. The Advisory Board is also selling its education division to San Francisco-based Vista Equity Partners for $1.55 billion. The Vista deal is expected to close by the end of this year or early 2018, after which the Advisory Board will complete its merger with Optum.
The Advisory Board’s shares rose 6.8 percent to $53 Tuesday after the deals were announced, the report states.
The Optum merger agreement is subject to contract conditions and regulatory compliance.
More articles on transactions and valuations:
14 recent hospital transactions and partnerships
2 Kansas hospitals to examine potential alliance
State OKs Regional Health’s purchase of 2 Washington hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
